A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
- Status
- RECRUITING
- Phase
- PHASE2
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
- Status
- RECRUITING
- Phase
- PHASE2
Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Squamous Cell Carcinoma (ESCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE2
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Status
- RECRUITING
- Phase
- PHASE3
PDT For Induction Therapy For Head And Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2